G Di Gioacchino

Emergency Unit, "Spirito Santo" Hospital, Pescara, Italy.

14 publications 1980 – 2021

What does G Di Gioacchino research?

G Di Gioacchino studies how stem cells can be used to repair damage in the liver and potentially transform into insulin-producing cells for people with diabetes. His research includes exploring the effects of human cord blood stem cells on liver recovery after injury and how stem cells can be converted into pancreatic cells that produce insulin. Additionally, he investigates the use of the Molecular Adsorbent Recycling System, a device designed to treat severe liver failure by filtering toxins from the blood, enhancing patient outcomes in liver disease.

Key findings

  • Human cord blood stem cells helped improve liver recovery in rats, with treated rats showing better healing after acute liver damage compared to untreated rats.
  • Stem cells can be turned into insulin-producing beta-like cells, potentially offering new treatments for diabetes, especially for those who cannot produce enough insulin.
  • In a study of 20 patients with severe liver failure, the use of the Molecular Adsorbent Recycling System improved brain function and kidney health, leading to better survival rates among patients with specific liver disease scores.

Frequently asked questions

Does Dr. Di Gioacchino study liver conditions?
Yes, he studies treatments for acute liver damage and severe liver failure.
What treatments has Dr. Di Gioacchino researched?
He has researched the use of stem cells for liver recovery and the Molecular Adsorbent Recycling System for treating severe liver failure.
Is Dr. Di Gioacchino's work relevant to diabetes patients?
Yes, his research focuses on how stem cells can potentially provide new treatments for patients with diabetes.

Publications in plain English

A case of vaccine-induced immune thrombotic thrombocytopenia with massive artero-venous thrombosis.

2021

Blood transfusion = Trasfusione del sangue

Turi MC, Spitaleri F, Gori AM, Parruti G, Rogolino AA +9 more

PubMed

Environment and T regulatory cells in allergy.

2012

The Science of the total environment

Braga M, Schiavone C, Di Gioacchino G, De Angelis I, Cavallucci E +3 more

Plain English
This study examined how certain immune cells, called T regulatory cells, react to harmless substances in our environment, especially in relation to allergies. Researchers found that in developing countries, the rise in allergies is closely linked to the increased use of harmful chemicals like pesticides, which seems to override the protective effects of common infections. Understanding this relationship is important because it highlights the need to address environmental pollution to help manage allergies. Who this helps: Patients suffering from allergies and healthcare providers working to treat them.

PubMed

Sublingual immunotherapy in children with allergic polysensitization.

2010

Allergy and asthma proceedings

Ciprandi G, Cadario G, Di Gioacchino GM, Gangemi S, Gasparini A +14 more

Plain English
This study looked at how effective a year of sublingual immunotherapy (SLIT) is for children in Italy who are allergic to multiple things (called polysensitization). Out of 51 children, the treatment led to a significant reduction in allergy symptoms, and they needed fewer medications to manage their allergies. The findings show that SLIT is safe and works well even for kids with multiple allergies, making it an important option for their treatment. Who this helps: This helps allergic children and their families by providing an effective treatment option.

PubMed

Improvement of mitochondrial function evaluated by ketoisocaproic acid breath test in patients with HCV infection undergoing albumin dialysis.

2005

Transplantation proceedings

Zocco MA, Di Campli C, Gaspari R, Candelli M, Nista EC +9 more

Plain English
This study looked at how a treatment called albumin dialysis (MARS) affects mitochondrial function in patients with chronic hepatitis C who were facing acute liver failure. The researchers found that after receiving MARS treatment, patients experienced a decrease in harmful substances in the blood and an improvement in mitochondrial function, as indicated by increased levels of specific ratios in their breath test. This is important because it shows that MARS treatment may help improve liver cell health in these patients, potentially easing their condition. Who this helps: This benefits patients with chronic hepatitis C and acute liver failure.

PubMed

From stem cell to solid organ. Bone marrow, peripheral blood or umbilical cord blood as favorable source?

2005

European review for medical and pharmacological sciences

Saulnier N, Di Campli C, Zocco MA, Di Gioacchino G, Novi M +1 more

Plain English
This study looked at different sources of stem cells—bone marrow, peripheral blood, and umbilical cord blood—and how they can be used for regenerative medicine, particularly in repairing damaged tissues. Researchers found that each source has unique properties that affect their ability to help heal, with new ways to determine which stem cells are the most effective. This matters because understanding which stem cells to use can improve treatments for various injuries and diseases. Who this helps: This helps patients needing tissue regeneration and doctors looking for effective treatment options.

PubMed

Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure.

2005

Transplantation proceedings

Di Campli C, Santoro MC, Gaspari R, Merra G, Zileri Dal Verme L +11 more

Plain English
This research examined the use of a device called the Molecular Adsorbent Recycling System (MARS) in treating patients with severe liver failure. The study involved 20 patients who had high bilirubin levels and severe liver complications. The results showed that MARS effectively reduced toxic levels in the blood, improved brain function, and enhanced kidney health, leading to better survival rates for patients with certain liver disease scores; specifically, those with scores between 20 and 29 experienced notable improvements. Who this helps: This research benefits patients suffering from severe liver failure and their doctors by providing a potential treatment option.

PubMed

Transdifferentiation of stem cells in pancreatic cells: state of the art.

2005

Transplantation proceedings

Di Gioacchino G, Di Campli C, Zocco MA, Piscaglia AC, Novi M +7 more

Plain English
This study explored how stem cells can be transformed into insulin-producing cells, which could be helpful for treating diabetes. Researchers found that stem cells from various sources, including embryonic cells and umbilical cord blood, can be guided to develop into beta-like cells that produce insulin. They observed that after bone marrow transplantations in mice, some of these altered cells were found in the pancreas, indicating potential for this approach. This work is important because it could lead to new treatments for people with diabetes, especially those who cannot produce enough insulin on their own. Who this helps: Patients with diabetes.

PubMed

Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats.

2005

Transplantation proceedings

Piscaglia AC, Di Campli C, Zocco MA, Di Gioacchino G, Novi M +10 more

Plain English
This study looked at how human cord blood stem cells could help repair damaged livers in rats after a harmful substance was injected. The researchers found that when these stem cells were given right after the liver damage, they helped reduce the damage and even turned into liver-like cells, improving the overall recovery. Specifically, the rats that received the stem cells showed better healing compared to those that didn’t, indicating a potential new treatment for liver injuries. Who this helps: This helps patients with acute liver damage and doctors treating them.

PubMed

Asthma worsened by benzoate contained in some antiasthmatic drugs.

2004

International journal of immunopathology and pharmacology

Balatsinou L, Di Gioacchino G, Sabatino G, Cavallucci E, Caruso R +5 more

Plain English
This study looked at how benzoate, a common additive in some asthma medications, can make asthma symptoms worse for certain patients who are sensitive to it. The researchers found that many allergic patients have reactions, like worsening asthma, due to these additives, which are often not correctly identified in their treatment. This is important because recognizing the impact of benzoate can help doctors provide better care for patients with asthma. Who this helps: Patients with asthma, especially those who are allergic or sensitive to food additives.

PubMed

Immune effects of nickel.

2004

International journal of immunopathology and pharmacology

Salsano F, Francia C, Roumpedaki I, Proietti M, Pisarri S +4 more

Plain English
This research focused on how nickel affects the immune system. The study found that nickel exposure reduces the activity of certain immune cells, specifically natural killer (NK) cells, and lowers the production of important immune substances like IL5, IFN gamma, and TNF alpha in individuals who are sensitive to nickel. This is significant because it suggests that nickel can harm the immune response in sensitive individuals, possibly contributing to health issues. Who this helps: This helps patients with nickel allergies and their doctors in understanding how nickel impacts their immune system.

PubMed

Occupational asthma due to low molecular weight agents.

2004

International journal of immunopathology and pharmacology

Di Stefano F, Verna N, Di Giampaolo L, Schiavone C, Di Gioacchino G +4 more

Plain English
This study looked at occupational asthma caused by low molecular weight agents, such as certain chemicals found in workplaces. Researchers found that exposure to these agents can lead to asthma symptoms in workers, and diagnosing this condition often requires specific tests alongside monitoring lung function. Recognizing and addressing these issues early can help prevent serious health problems for affected workers. Who this helps: This helps workers in industries exposed to harmful chemicals and their healthcare providers.

PubMed

[The emergency refund system in Lazio region: features and problems].

2004

Annali di igiene : medicina preventiva e di comunita

Guasticchi G, Benedetto FR, Di Gioacchino GV

Plain English
This study looks at how the Lazio region's emergency healthcare system tracks and funds emergency department visits. In 2000, there were nearly 2 million emergency admissions, which increased to over 2.1 million in 2001, costing the region about 145.6 million Euros in 2000 and 170 million Euros the following year. The research highlights issues in the way financial evaluations are calculated, which is important for ensuring that health services are funded appropriately. Who this helps: This benefits patients and healthcare providers by improving the efficiency and funding of emergency services.

PubMed

Prevalence and risk factors for latex-related diseases among healthcare workers in an Italian general hospital.

2003

Annals of clinical and laboratory science

Verna N, Di Giampaolo L, Renzetti A, Balatsinou L, Di Stefano F +5 more

Plain English
This study looked at how common latex allergies are among healthcare workers in an Italian hospital and what factors may increase the risk of developing these allergies. Out of 284 workers surveyed, 47% reported symptoms related to latex use, while 12% were confirmed to have an allergy, with a higher likelihood among those with other allergic conditions and longer exposure to latex gloves. Understanding these risks is important to help protect healthcare workers and improve workplace safety. Who this helps: This helps healthcare workers, their employers, and occupational health professionals.

PubMed

[Interruption of atrial flutter and supraventricular paroxysmal tachycardia by temporary electrostimulation (personal case studies)].

1980

Bollettino della Societa italiana di cardiologia

Mobilij A, D'Annunzio E, Zambelli P, Cerasa V, D'Orazio G +2 more

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.